ISSAD.org
@issadgbs.bsky.social
Now that our #ISSAD2026 delegates are back home and settled into their routines, we want to say a huge THANK YOU for making the 4th International Symposium on Streptoccocus agalactiae disease so impactful.
#GBS #ISSAD2026 Plenary 5 at #ISSAD2026 has taken us From Evidence to Action. We’re moving beyond the lab to talk about how we actually reach the mothers and babies who need these vaccines most.
Because a vaccine only works if it's accessible, sustainable, and safe for everyone.
#ISSAD #GlobalHealth The science of GBS vaccines is advancing rapidly, but how do we implement them? In Plenary 4, we look at the evidence and economics behind the rollout.
#ISSAD2026 #GBS #GlobalHealth Plenary 1 at #ISSAD2026 is diving deep into the Disease Burden & Surveillance of Group B Strep. We’re moving beyond the basics to look at infant impact, adult disease, and the genetic "fingerprints" of GBS across the globe.
From Evidence to Action.
#ISSAD2026 #GBS #FromEvidenceToAction How can we improve GBS diagnosis at the point of care? Nexsen Bio’s Prof. Vipul Bansal will be at #ISSAD2026
Session: Plenary C: Advancements in Diagnostics
Speaker: Prof. Vipul Bansal
Time: Tue, 24th Feb, 4:00 PM EAT
Venue: Hyatt Regency Westlands Nairobi (Muthithu)
#ISSAD #GBS #MaternalHealth Dr. Karen Puopolo’s career is in translating basic science into clinical practice.
Most notably, Dr. Puopolo has been instrumental in leading the revised U.S. national guidance for managing infants at risk for GBS disease.
Find her at #ISSAD2026
#ISSAD #GBS #MaternalHealth Prof. Jane Daniels is the mind behind GBS3; one of the largest GBS clinical trials. Her work is answering the question: Should we test every mother for GBS, or stick to risk-factor strategies?
Don't miss her session at #ISSAD2026
📅23 - 25 February, 2026
📍Nairobi, Kenya Kenya Medical Association (KMA) are in #ISSAD2026 with a mission to champion the welfare of doctors and the health of the public.
We look forward to a symposium enriched by the expertise of Kenya’s medical professionals.
#ISSAD2026 #KMA #PublicHealth #GBS Prof. Violet Naanyu is a speaker at #ISSAD2026!
She is a champion of community-engaged research and human-centered design, ensuring that global health solutions are built alongside the people they serve.
#ISSAD #MaternalHealth #PublicHealth Registration for #ISSAD2026 is officially CLOSED!
We are overwhelmed by the incredible response from the scientific and medical community. Thank you to everyone who joins us in the fight against Group B Strep.
See you in the green city under the sun!
#ISSAD #GlobalHealth #Nairobi Dr. Ignacio Esteban is a pediatrician and epidemiologist whose career has been defined by a commitment to maternal and neonatal health.
Welcome to the #ISSAD2026 lineup, Ignacio! 👏
📅23 - 25 February, 2026
📍Nairobi, Kenya
#ISSAD #MaternalHealth #GBS #NewbornSafety From groundbreaking clinical trials to national surveillance, KEMRI has been In Search of Better Health for over 40 years. Now, they are helping host #ISSAD2026.
Join us in Nairobi to bridge the gap between world-class research & life-saving policy.
#GBS #MaternalHealth Dr. Martha Mandale serves as Principal Regulatory Officer within Kenya's Pharmacy and Poisons Board, her focus residing at the intersection of pharmacovigilance and maternal-neonatal health.
📅23 - 25 February, 2026
📍Nairobi, Kenya
#PublicHealth #MaternalHealth #VaccineSafety #GBS Welcoming Prof. Michelle Groome to #ISSAD2026!
With 20 years of expertise in infectious diseases & vaccinology, Prof. Groome has been a driving force in vaccine trials and disease surveillance.
📅23 - 25 February, 2026
📍Nairobi, Kenya
#GBS #MaternalHealth #MIRNA #GlobalHealth We are proud to have Prof. Kwaku Poku Asante at #ISSAD2026!
His insights on conducting high-impact clinical research in the African context will be invaluable.
📅23 - 25 February, 2026
📍Nairobi, Kenya
#GBS #ISSAD #Epidemiology #GlobalHealth Dr. Roberto Adamo is a veteran of the vaccine industry with nearly two decades of experience leading projects at GSK & @novartis.bsky.social
At #ISSAD2026, he will share his expertise on glycoconjugate vaccines & the platforms enabling the next generation of life-saving interventions. Prof Alfred Osoti stands at the forefront with the leaders shaping women’s health in Kenya and beyond.
We are honored to have him share his insights at #ISSAD2026 this February!
📅23 - 25 February, 2026
📍Nairobi, Kenya
From Evidence to Action.
Register: issad.org/registration
#GBS #GlobalHealth With just 25 spots left in the room, the window to join the most critical GBS vaccine dialogue of the decade is closing.
Register to secure your seat: issad.org/registration
From Evidence to Action.
📅23 - 25 February, 2026
📍Nairobi, Kenya
#GBSAwareness #MaternalHealth #ISSAD2026 #GBS Dr. Nisar’s work is at the cutting edge of implementation research.
Join #ISSAD2026 to hear him discuss the critical bridge between GBS research and real-world health policy.
📅23 - 25 February, 2026
📍Nairobi
From Evidence to Action.
#GBS #MaternalHealth #AgaKhanUniversity As an Obstetrician/Gynecologist and clinical researcher at @makerere University School of Medicine, Dr. Nakabembe is a leading authority on vaccine safety and immunogenicity during pregnancy.
Find her at #ISSAD2026
📅23 - 25 February,
📍Nairobi, Kenya
From Evidence to Action.
#GBS #MaternalHealth We welcome Dr. Simon Procter, Assistant Professor at the London School of Hygiene and Tropical Medicine (LSHTM), to ISSAD 2026.
📅23 - 25 February, 2026
📍Nairobi, Kenya
#LSHTM #GBS #GlobalHealth Save the Date for #ISSAD2026!
📅23 - 25 February, 2026
📍Nairobi, Kenya
Three days of cutting-edge science, policy breakthroughs, and powerful networking.
From Evidence to Action.
Register: issad.org/registration
#GBSAwareness #MaternalHealth #ISSAD #GBS While teaching in Kenya, Dr. Anne Maina discovered a critical lack of GBS screening data & inspired her students to fill that gap, leading to a landmark publication on neonatal sepsis.
Find her at #ISSAD2026
📅23 - 25 February, 2026
📍Nairobi, Kenya
From Evidence to Action. Clare Cutland is the force behind the Afro-ADVAC course and Wits-ALIVE’s vaccinology programs. She’s a world-class researcher with 150+ publications on maternal & infant health.
Find her at #ISSAD2026
📅23 - 25 February, 2026
📍Nairobi, Kenya
#GBS #GBSPrevention #GlobalHealth From the Rio de Janeiro labs, PhD. Tatiana Pinto's research investigates everything; genomic epidemiology, virulence & drug resistance.
Find her at #ISSAD2026
📅23 - 25 February, 2026
📍Nairobi, Kenya
From Evidence to Action.
#GBS #GBSPrevention #GlobalHealth Honored to announce Dr. Stephanie Schrag for #ISSAD2026!
✔️ 25 years leading @CDCgov GBS & Neonatal Sepsis programs
✔️ Co-led CDC’s COVID-19 vaccine effectiveness team
✔️ Author of 180+ publications
✔️ WHO scientific contributor
Find her at #ISSAD2026
📅23 - 25 February, 2026
#GBS #CDC #ISSAD With less than 50 seats left for the main event, now is the time to get your questions answered.
We’re going LIVE with Dr. Hellen Barsosio on X and LinkedIn to help you prepare for #ISSAD2026!
Clear your calendar for JAN 27, 7PM EAT.
Got a question? Leave it in the comments. Ever wonder how we track the impact of Group B Strep across the population? Meet Namrata Prasad, an epidemiologist at the CDC.
Find her at #ISSAD2026
📅24 - 26 February, 2026
📍Nairobi, Kenya
From Evidence to Action.
Register: issad.org/registration
#CDC #GBS From leading KEMRI’s multi-continent MIRNA study to consulting for Kenya’s Ministry of Health, Julie Nyanchama is a powerhouse in maternal and newborn health.
From Evidence to Action.
Register: issad.org/registration
📅24 - 26 February, 2026
📍Nairobi, Kenya
#ISSAD26 #GBS Oliver Plumb FRSA, Advocacy & Information Manager at Group B Strep Support (GBSS), is a moderator for #ISSAD2026! He ensures GBS remains a priority on the national health agenda.
📅23 - 25 February, 2026
📍Nairobi, Kenya
#ISSAD2026 #GBS #FromEvidencetoAction#PublicHealth #MaternalHealth Happy New Year!
We gear up for the 4th International Symposium on ‘Streptococcus agalactiae’ Disease (ISSAD) conference next month & renew our commitment to better patient outcomes.
Resolution: Finalize travel plans!
24-26 February, 2026
#ISSAD2026 #FromEvidencetoAction #GBS Dr Dorota Jamrozy (Wellcome Sanger Institute) is joining #ISSAD2026!
As scientific lead for the Juno Study, she'll present critical data on the genetics & evolution of Group B Streptococcus (GBS)
From Evidence to Action
Register: issad.org/registration
#ISSAD2026 #GBS
@sangerinstitute.bsky.social 
